Avita Medical
RCEL
56 hedge funds and large institutions have $24.2M invested in Avita Medical in 2022 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 10 increasing their positions, 20 reducing their positions, and 24 closing their positions.
2,865% more call options, than puts
Call options by funds: $3.41M | Put options by funds: $115K
7.3% less ownership
Funds ownership: 27.61% → 20.31% (-7.3%)
19% less funds holding
Funds holding: 69 → 56 (-13)
42% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 24
50% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 20
58% less capital invested
Capital invested by funds: $58.3M → $24.2M (-$34.1M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$1.65M |
| 2 |
Renaissance Technologies
New York
|
+$692K |
| 3 |
E
Ergoteles
New York
|
+$630K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$538K |
| 5 |
PVI
Pura Vida Investments
New York
|
+$417K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$6.74M |
| 2 |
State Street
Boston,
Massachusetts
|
-$2.07M |
| 3 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$1.36M |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$1.2M |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$1.07M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
76
Nisa Investment Advisors
St. Louis,
Missouri
| – | -$14K | -1,700 | Closed |
|
77
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| – | -$3K | -389 | Closed |
|
|
SPIA
78
Steward Partners Investment Advisory
New York
| – | -$2K | -195 | Closed |
|
|
CS
79
Credit Suisse
Zurich,
Switzerland
| – | +$80 | +13 | New |
|
RCEL Hedge Fund Activity: Q2 2022 in Review
56 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Avita Medical (RCEL) for Q2 2022, worth a combined $24.2M — down 58% from $58.3M a quarter earlier.
Sellers outnumbered buyers: 24 funds closed out of RCEL and 14 opened new positions — a net loss of 10 holders — while 20 trimmed existing stakes and 10 added.
The largest buyer was Millennium Management, opening a new position worth an estimated $1.65M. The largest seller was BlackRock, cutting an estimated $6.74M.
- 56 institutional investors held Avita Medical (RCEL) as of Q2 2022, down from 69 in Q1 2022.
- Funds reported $24.2M of Avita Medical stock for Q2 2022, down 58% quarter-over-quarter.
- 14 funds opened new Avita Medical positions in Q2 2022 and 24 closed out, a net change of -10 holders.
- The largest Avita Medical buyer in Q2 2022 was Millennium Management, an estimated $1.65M added.
- The largest Avita Medical seller in Q2 2022 was BlackRock, an estimated $6.74M sold.
Based on aggregated 13F filings for Q2 2022.